DGXNEUTRAL

DGX Return on Equity (ROE) Analysis

14.6%

Higher than 67% of Healthcare sector peers

Updated 581h ago·SEC filings & market data

Key Takeaway

Return on equity (ROE) measures how much profit a company generates from each dollar of shareholder equity; at 14.6%, Quest Diagnostics earns $14.60 for every $100 of equity invested.

Sector Performance

67th percentile

DGX

14.6%

Sector Median

11.3%

Sector Avg

72.2%

Prior Period

14.5%(Jul 2026)

→ Stable
📊

Deep Analysis

Return on equity (ROE) measures how much profit a company generates from each dollar of shareholder equity; at 14.6%, Quest Diagnostics earns $14.60 for every $100 of equity invested.

This is above the healthcare sector median of 8.9%, placing the company in the 66th percentile of its peers, indicating better-than-average profitability. The year-over-year change is not available, while the quarter-over-quarter change is +0.7%, with the most recent values showing a slight rise from 14.5% to 14.6%. The lack of a longer trend makes it difficult to judge momentum, but the high relative level suggests efficient use of capital with limited immediate downside. The combination of an above-median ROE and only a small quarterly increase implies steady performance rather than accelerating opportunity. This metric supports the overall NEUTRAL verdict, as the return is solid but not exceptional enough to justify a bullish or bearish tilt.

Frequently Asked Questions

What does the Return on Equity (ROE) tell investors about DGX?

ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.

How is the Return on Equity (ROE) calculated?

Return on Equity (ROE) is calculated as: Net Income / Shareholders' Equity.

How does DGX's Return on Equity (ROE) compare to its sector?

DGX's Return on Equity (ROE) of 14.6% compares to a Healthcare sector median of 11.3%, placing it in the 67th percentile.

Who are DGX's closest peers by Return on Equity (ROE)?

The closest Healthcare peers by Return on Equity (ROE) include: ABT (12.5%), ALGN (10.1%), TMO (13.5%), TECH (9.0%), VEEV (13.9%).

The Formula

Net Income / Shareholders' Equity

Why It Matters

ROE measures how effectively management turns equity into profit. Consistently above 15% is typically considered strong. Negative equity distorts this metric.

Advertisement

Master DGX's Valuation

Get the complete institutional research report covering all fundamental and technical metrics.

View full DGX research report

Free account — no credit card

DGX

14.6%

Sector Median

11.3%

Sector Avg

72.2%

How DGX's Return on Equity (ROE) compares to sector peers.

Not financial advice. Research tool only. Data may be delayed.